Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current soft-tissue sarcoma classifications.

S Daugaard1

  • 1Department of Pathology 5443, Rigshospitalet, Frederik V's Vej 11, DK-2100 Copenhagen Ø, Denmark. sarcpath@rh.dk

European Journal of Cancer (Oxford, England : 1990)
|February 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individual and work-unit measures of psychological demands and decision latitude and the use of antihypertensive medication.

International archives of occupational and environmental health·2014
Same author

Delayed dental maturity in dentitions with agenesis of mandibular second premolars.

Orthodontics & craniofacial research·2010
Same author

Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma Group.

Sarcoma·2008
Same author

Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group.

European journal of cancer (Oxford, England : 1990)·2007
Same author

Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas.

European journal of cancer (Oxford, England : 1990)·2006
Same author

Sinonasal schwannoma--a clinicopathological analysis of five rare cases.

Rhinology·2006
Same journal

Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinical urgency of incidental findings in the first year of the 4-IN-THE-LUNG-RUN lung cancer screening program.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

European journal of cancer (Oxford, England : 1990)·2026
See all related articles

Modern sarcoma classification significantly altered diagnoses of extremity soft-tissue sarcomas (STS). Reclassification revealed changes in common STS types, impacting retrospective research due to advances in immunohistochemistry (IHC).

Area of Science:

  • Oncology
  • Pathology
  • Surgical Pathology

Background:

  • Soft-tissue sarcomas (STS) were historically diagnosed using older classification systems.
  • Malignant fibrous histiocytoma (MFH) and fibrosarcoma were frequent diagnoses in earlier STS classifications.
  • Advances in diagnostic techniques and nomenclature have prompted re-evaluation of STS classifications.

Purpose of the Study:

  • To analyze the impact of modern sarcoma classification criteria on extremity STS diagnoses.
  • To re-evaluate pathological material from STS cases diagnosed between 1972 and 1994.
  • To assess changes in diagnostic proportions and identify reasons for diagnostic shifts.

Main Methods:

  • Retrospective review of pathological material from 281 extremity STS cases.

Related Experiment Videos

  • Reclassification of cases based on current diagnostic criteria and advances in immunohistochemistry (IHC).
  • Comparison of original diagnoses with reclassified diagnoses, noting changes and reasons.

    • Main Results:

    • Reclassification significantly altered diagnostic proportions; leiomyosarcomas became the largest group (20%).
    • Original diagnoses were changed in 57% of cases, with substantial reductions in MFH and fibrosarcoma.
    • 20 cases (7%) were reclassified as non-sarcomatous; 22 were identified as myxofibrosarcomas.

    Conclusions:

    • Modern sarcoma classification criteria, supported by immunohistochemistry (IHC) and updated nomenclature, have significantly revised STS diagnoses.
    • The high rate of diagnostic change underscores the limitations of older classifications for retrospective studies.
    • Findings highlight the need for updated diagnostic standards in sarcoma research and clinical practice.